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Specific detection of fibroblasts has been one of the 
unsolved probleJTIs in cell biology. Because JTIonoclo-
nal antibodies (MoAbs) might provide an easy and 
reproducible method of fibroblast detection, we have 
produced a panel ofMoAbs raised against cell surface 
proteins of human dermal fibroblasts. Using flow 
cytometry and ilTImunohistochemistry, we have 
shown that two of these MoAbs, FibASOl and 
FibAS02, react exclusively with hUJTIan fibroblasts. 
They do not react ;11 ,,;t/fO with human keratinocytes, 
endothelial cells, or blood cells. Immunohistologic 
experiments investigating the binding pattern of the 
MoAbs FibASOl and FibAS02 in cryostat sections of 
different tissues confirmed the flow cytometric re-
sults . In human skin, the antibodies exclusively la-
N 0 spec~fic antibody is availab ~e that exclusivel y recoglllzes fibroblasts. An antibody agalllst pro-Iinc-4-hydrmcylase has bcen used to detect fibro-b lasts, but prolin e-4-hydroA.)dase is a marker of collagen-produ cing ce lls and is therefore not re-
stricted to fibroblasts (H6yhtyii ct ai, 1984; Esterre el ai, 1992).Janin 
et al (1990) d escribed the exprcssion of this en zymc in endothe lial 
cells. smooth muscle ce lls, gland ce lls. plasma ce lls, and chondro-
cytes. Furthermorc, antibodies fa il to sta in quiescent fibrob lasts 
~ith li ttle o r no collagen production Oanin el ai, '1990) . An 
a dditional disadvantage of this antibody is the intrace llul ar loca l-
ization of the antigen, which necess itates di sruption of the cell 
rncm brane for detection. Therefore, ce ll separation procedures and 
Eu rther ce ll c ultures of separated cells with this antibody arc 
impossible. Other antibod ies used in fibrob last identification show 
cross-reactivity with m onocytes, macrophages, smooth muscle ce ll s 
(Kay el ai, 1989; Ronnov-Jessen 1:1 (/1, 1992), and matrix compo-
nents (Van Vliet cI ai, 1986), or they react only with a part of the 
~hole fibroblast population (Steve ns el ai, 1990). 
The absence of any fibrob last-speci fi c marke rs ex plains w h y 
some important issues remain unsolved. A monoclona l antibody to 
a fibrob last surface prote in would bc a powerful tool for address ing 
these issues. For examp le, the chara cterization of ce ll lin es is 
inlportant for the correlation of ce ll cultures with tissue orig in and 
identification of the stages of differentiation and the ce ll type to 
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beled fibroblasts. In other human tissues such 
as lymph nodes, placenta, kidney, muscle, thyroid 
gland, gall bladder, cartilage, and tendon, the spec-
ificity for fibroblasts was borne out. Neither antibody 
reacts with fibroblasts from n"louse, rat, or pig. The 
isotype was defined as an IgGl for both. By western 
blot analysis, both antibodies detected a molecule of 
60-65 kDa under reducing and nonreducing condi-
tions. By inlmunoelectron microscopy, we observed 
the antigens on the cell surface without any cluster-
ing at specific sites. These data demonstrate that the 
two MoAbs, FibASOl and FibAS02, exclusively recog_ 
nize human fibroblasts. Key 1V0/.ds: lIIo,,0c/01lal alltibod-
ieslfil1Yoblasts. ] [11 vest Demratol 106:1314-1319, 1996 
w hich the ce lls belong (Aiba et ai, 1994). Another very common 
problem is th e ovcrgrowth of different ce ll cultures (epithelial and 
e ndothe lial cells, c ho ndrocytes, macrophages) by fibroblasts (Kay er 
(/1, 1989). T he identification and the se lective elimination of these 
contaminants are necessary for many experiments. Usually fibro-
blasts are prepared by o utgrowth fi'o l11 biopsies. All alternative 
m e thod would be direct isolation of fibroblasts fi'om enzymatically 
digested biopsies with a specific antibody. 
In th is study, we describe the properties and specificity of novel 
monoclona l antibodies (MoAbs) raised against fibroblast surface 
proteins. In Aow cytometri c and immullohistochemical studies, we 
show that both antibodi es react specifica lly with fibrob lasts . 
MATElUALS AND METHODS 
Allti-CD29, anti-CD3 J. anti-CD l 5, anti-CD14, anti-v imentin, and fluo_ 
rescein isothiocyanatc-conjugated goat-nnti-rnollsc 1\ ,h)2 fragnlcnts \\'cre 
frolll IlIlmunotech (Hamburg, German y); <II,ti-fibrob last (prolinc-4-hy_ 
droxylase). goat-anti-mouse, and alkaline phosphatase anti-alkaline phos_ 
phatase complex were from Dako (Carpinteria. CAl; anti-coUagen IV. 
anti-lam in in , and anti-fibronectin were from Sigma (St. Louis. MO); 
anti-cytokeratin 14 was from Scrva (Heidelberg. Germany); anti-coUagcn 
I- III wa5fi'om Monosan (Am Uden , Netherlands); and anti-CD45 was fron1 
Coul ter (H inleah. FL). 
IltlJllUnizatiolt and Cell Fusion We il11111Ul1i zeo Balb/c Inice intrapcri_ 
tonea lly with hU lllan fibrob lasts and l1lembrane fragl1lent fractions of - 1 X 
107 human fibrob lasts 9 '1I1d 3 weeks before booster immuniza tion. Spleen 
ce ll s wcre fused with X63-Ag.8 .653 m)'cIolna cell s using polyethylene 
glycol according to the principle 0([(61Ier and Milstein (1975) . Hybridom3 
supernatan ts were screened for antibodies binding to cultured Inllllan 
fibroblasts by applying immunofluorescence and flow cytollletry. Hybrid_ 
011101 supernatant was lI sed undiluted in ini tia l testing. Supernatants of 
establi.shed hyb ridolllas could be used ill a 1 :20 di lu tion. Two clones of 
interest wcre selected and rccloned. alld stable hybridoma clones were 
established . 
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Cell Preparation Fibroblasts were obta ined after outgrowth fro m biop-
sies of skin, heart, and nasa l mucosa. The cell s were cultured in Dulbecco 's 
modified Eagle's medium-Glutamax (Gibco, Gai thcrsburg, MD) , supple-
mented 'with 10% fetal c"lfserum (Gibco), 50 mg/l ascorbic acid, 50 ILg/ml 
screpto n~ycin , and 400 U / ml penicillin and were passaged after reaching 
conflu e n ce using 0.05'1., trypsin , 0.02% ethylcnediamine tetra acetic acid 
(EDT A) (Gibco). T he ceUs were used up to the seventh passage. Human 
dem~al lnicrovascular endothcl.ial ce lls were isolated from neonatal foreskin 
as described by Karasck (1989) and cultured in Iscove's modifi ed Dulbcc-
co's = eruum (Gibco) supplemented with thymidine (3.6 mg/ml), hypoxan-
thin e (13.6 mg/ml) , dibu tyryl cycl ic AMP (24.5 mg/ ml) , isobutyl methyl 
xanthin e (36.6 mg/ml) . fetal ca lf serum (8'Yo). and human prepartum serum 
(2%). H u.n,an umbili cal vein endothelial ce lls wcre prepared acco rding to 
standard protocols Oaffc ct ai, 1973) and cultured in M1 99 medium (Gibco) 
supplen,ented with 20 mg/ml endothelial cel.l growth factor. 50 mg/ml 
heparin, 10% fetal calf serum , and 10% human serum. I-luman epidermal 
keratinocytes obtained fro m thc foreskin were cu ltured in se rum-free 
medium. (KGM, Clonetics . San Diego. CAl (Ship ley and Pittelkow. 1987). 
Djspase II (Boehringer Manl1heim, Indianapolis, IN) was used to separate 
the epidermis fi'om the dermis. The epidermal tissue was digested with 
trYpsinIEDTA after stripping and splicing (Gibco) . The trypsination was 
stopp e d b y KGM containing Ultroser G (Gibco). T he ce lls were seeded in 
a concentration of 4000-8000 ce ll s/cm 2 and aU owed to grow under 
stand ard cell culture conditions in de filled KGM adjusted to 0.1 5 mM 
calciulTI concentration . Lymphocytes and monocytes were prepared from 
EDTA-blood by density gradient centrifugation using Ficoll-1'aque (1'ha.l"-
macia B i otech, Piscataway. NJ) for ;11 1';/ro lymphocyte isolation. Granulo-
cytes vvere also prepared l1-om EDTA-blood by density gradient centrifu-
gation u s ing Ficoll with a deIlSity of 1.078 g/cm' . T lu'ombocytes were 
obtained fi'om plasma of human EDTA-blood . The plasma was centrifuged 
at 1500 X g for 10 min. 
floW" Cyt:ometric Analysis Cell mono layers were detached by 0.05% 
tryps in, 0.02% EDTA (Gibco) and was hed two times with phosphate-
buffered saline (PBS). Prepared blood cells were washed three times with 
PBS. Cells (2 X 105 ) were incubated with 50 ILl of bybridoma culture 
supernatan t in concentrated form for 45 min at 4°C. Contro l samples were 
incubated with irrelevant matched isotype MoAbs o r positive control 
anti b o di es. After washing with PBS/l 0% Gelafusa l, the cell s were incubated 
for 45 n,in at 4°C with a fluoresce in isothiocyanatc-conjugated goat-anti-
[IlOu se antibody, washed three times, and fi xed in PBS/ I O% Gelafusal with 
1% fOrTI, aldehyde. The final evaluation was performed using flow cytometry 
with an EPICS-Flowcytometer (Coulter). 
InUD.un.ohistologic Studies Frozen biopsies from different tissues were 
cut in 4 - to 6-ILm-thick sections. fixed with acetone for 10 min, and dried . 
Sections vvere incubated for 1 h with undilu ted hybridoma superna tant and 
then with goat-anti-mouse antibody and alkaline phosphatase anti-alkaline 
phosphatase complex. Wash.ing was performed with 0.9% NaC1/0.05 .M 
Tris-HCl, pH 7.4 . Bound antibodies were detected by a color reaction WIth 
New F u c h sin (Serva) and naphthol as biphosphate (Sigma). For double-
staining experiments, the antibody was purified from the culture superna-
tallt b y Protein G-Sepharose chro matography (MoAb T rapll kit, Pharmacia 
Biotech) a nd was concentrated by ultra filtra tion. The purified antibodies 
were bioti~nylated with the D-biotinyl-amidocaproic acid N-hydrox ysuccin-
imid e es ter (Boehringer Mannheim). T he working dilution was dependent 
on protein concentration as "veU as on biotinylation efficiency and was 
detern, in e d by Bow cytometry. Biotinylated antibody (dilution, 1:100; final 
protein c oncentration , - 10 ILg/ml) was detected w ith a streptavidin-
peroxidase-conjugate (IJnlllunotech. H al11burg, GCfrnan y) and dianlinoben-
zidine and H2 0 2 as enzyme substrate in hi stologic sections. 
IIIlIl:l Unoelcctron Microscopy T he skin spec imen was cut with a razor 
blade iuto 1-nu11' blocks. washed in PBS, and exposed for 24 h to the MoAb 
fibAS02 h ybridoma supernat'Ult diluted l :J O. N orma l mouse serum (dilu-
ti011, 1: 1 0) was used as a control. After several washes in PBS, the specimens 
wer e exposed for 24 h to a secondary antibody consisting of 5 nm gold 
conj u gated to a goat-anti-mouse IgG (AuroProbe , Amersham. Bucking-
hamshire , U K) in 20 mM Tris H CI. 0.15 M NaC I, and 20 mM sodium az ide 
containing 0.1 % bovine serum albumin. T he specimens were washed in PBS 
and fixe d in Karno wsky's solution for 3 h (Karnowsky, 1965). T he 
specirrlens were rinsed in O. l M cacodylate buffer. pH 7.4, post-fixed in 1 % 
osmiun'l tetroxide for 1 h, and stained "en bloc" \·..,lth 1 cYo aqueous phos-
photungstic acid and 2% aqueous uran yl acetate for 1 h . After dehydration in 
grad e d a l cohols and propylene oxide. the specimens were embedded in 
Spu='s resin. Ultra-thin sections were obtained. collected on 400 mesh 
nickel grids, and examined in a Zeiss EM900 electron microscope. 
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Reactiv ity to Collagen I, III, IV, Fibronectin, and Lalninin Col-
lagen I, III , IV, and laminin were purchased frolll Sigm a. Collagen I (20 
ILg/ ml) , coll age n III (20 (.Lg/ ml) . coUagen IV (5 (.Lg/ ml ). and laminin (5 
ILg/ml) were mixed and bo und to plastic plates overnight at 4°C . washed 
three times with PllS/O.05% Tween 20. and blocked fo r 30 min at 4°C with 
PBS / 10% boville se rum albumin (Serva: Heidelberg). After 4 h of incuba-
tion at 4°C with the hybridoma supernata nt and control antibodies to 
co llagen 1-.111 , collagen IV. and laminin , the wash.ing was repeated and the 
plate was incubated with a goa t-anti-mouse antibody conjugated w ith 
horseradish peroxidase (Sigma) dilu ted in PBS/ 1 % bovine serum albumin. 
After washing, bound antibodies were detected by a color reaction with 
a-phenylenediamine dihydrochloride (Sigma) and H 20 2 at 490 Ilm. Fi-
bronectin was purchased from Serva. Plastic plates were covered with 20 
ILg/ ml fibronectin at 4°C overnight. and detection was performed as 
described above in a separate assay . Anti-fib ronectin antibody trom Sigma 
was used as control. 
Isotypc Detection The isotype detection of the MoAbs was performed 
with the m ouse monoclonal isotyping ki t (Sigma) according to the m an u-
f.1cturer' s protocol. 
Molecular Weight Determination Fibroblasts were detached with 
trypsin/EDTA and washed w ith PBS. Memhrone proteins were solubilized 
with 0.5°A, T rito n Xl00 in PBS containing 1 mM phenylmethylsulfonyl 
Au oride for 30 min and centrifilged (l0.000 X g fo r 5 min at 4°C). The 
prepared samples were separated c1ectrophorctically under reducing or 
nonreducing conditions on a 7.5% sodium dodecyl sul f.,te-polyacrylamide 
gel electrophoresis using a discontinuous buffer system according to 
L1emmli (1 970). Mo lecular weight markers (Sigma) were run for la ter 
estimation of the molecular weight. T he proteins were transferred to 
nitrocellulose membranes (Schleicher & SchucH. Keene, NH), blocked for 
2 h w ith 5% non- f.1t milk powder in PBS, and trea ted overnigh t at 4°C with 
undiluted hybridoma culture supernatant . After washing, bound antibody 
wos detected using a goat-anti-mo use antibody conjugated with aIkaHne 
phosphatase. Disodium 3- ( 4-methoxyspiro( 1 ,2-dioxetane- 3 ,2 ' - (5' -chloro) 
tricyclo[3.3.1 .13 •7 jdecan}- 4-yl)phenylphosphate (Tropix. Bedford, MA) 
was app li ed to generate an enhanced chemiluminescence signa l on ECL-
films (Amersham). 
R ESULTS 
W e were abl e to establish > 10 stabl e h ybrido ma clones. In this 
study, we describe the m ost interestin g antibodies (MoAbs FibASOl 
and FibAS02) with respect to their ability to d etect fibroblasts. 
MoAbs FibASOl and FibAS02 sh owed similar binding pattems b y 
flow cytom e try and immunohistolog ic stueties. T h e characteri stics 
of M DAb FibAS02 de monstrated in the fi g ures are very similar to 
those of FibAS01. Both M oAb s b elong to the IgGl subclass. 
Flow Cytometry Analysis of Binding Pattern of MoAb 
FibAS02 By indirect immuno fluorescen ce m e thods , we tested 
the reaction Df the MoAb to diffe rent types of cell s, su ch as human 
fibrDblasts, keratinocytes, endoth e lial cell s, monocytes, lymphD-
cytes, thrDmbocytes, and granulocytes (Fig 1). T h e reac tivity Df 
MoAb FibAS02 was limite d to fibroblasts; n e ithe r keratinocytes nOr 
endo the lial cell s were recognized. Additionally, all fibroblasts were 
sta ined with anti proline- 4-hydroxylase MoAb and CD29, a ll 
endDthelial cell s were sta ine d with CD3 1 M oAb, and a ll k e rati n o -
cytes were stained with cytokeratin 1 4 MoAb and CD29 MoAb as 
positive con t rol s resp ectively. The analysis of blood cell s (lymphD-
cytes, monocytes, granulocytes, and thrombocytes) demDn str ated 
that the binding of MoAb FibAS02 was nDt d etectable On an y of the 
blood cell typ es tested (Fig 1) . The expression Df CD45 on 
lymphocytes, of CD14 o n m o nocytes, Df CD15 o n granulocytes, 
and of CD29 Dn thrDmbocytes was used as pDsitive cDntrols . 
All fibro blasts Df different tissue origins, including fo reskin, skin , 
h eart, nasal mucosa , and e mbryonic lung, reacted with th e MDAb 
FibAS02 (data n o t shown). Interesting ly, human fibroblasts from 
granul.ation tissue obtained 3 and 6 d after wounding shDwed 
increased binding Df M DAb FibAS02. A fter 6 d, the expressiDn 
d ecreased and approached the level of quiescent fibroblasts (Fig 2). 
T he express iDn of the correspondin g an tigen Df FibAS02 Dn 
fibroblasts in different ce ll p assages, o n confluent and subconfluent 
cultures, or on cultures with differe nt feta l bovine serum con cen-
trations in the m edium remained unchanged by fl ow cytDm etry 
(data nDt shown) . 
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Figure 1. The MoAb FibAS02 reacts exclusively with fibroblasts 
investigated by Bow cytometry (IMck lilies) . The fo llowing MoAbs 
were used as positive controls (",enker /ill es) for the corresponding ce ll types : 
CD29-fibroblasts, CD29-keratinocytes, CD3 1-endothcl ial ce lls. CD45-
lymphocytes, CD14-t1Ionocytes, CD15-gran ulocytes, CD29-thrombocytes. 
The MoAb FibAS01 ·showed the same binding patte rn as that of 
MoAb FibAS02. 
Immunoh istologic Investiga tions o f Skin Sections Next 
we examined the correlatio n of the ill vit ro data w ith the i ll silll 
situation in the skin . In Fig 3A, the di str ibu tion o f the antigen in 
intact skin is shown. III agreem en t w ith the distribution of fibro -
blasts, the dermis was stained in tensively by MoAb FibAS02. 
Kera tinocytes of the epidermis and hair fo llicles sho wed 11 0 binding 
of MoA b FibAS02, w hereas fi broblas ts in the connective root 
sheath were sta in ed strongly (Fig 3B) . Notabl y, M oA b FibAS02 
strongly labeled fi b robIasts aro und blood vesse ls, hair follicles and 
g lands. T he cell s of the sweat glands and sebaceous gland; and 
smooth m uscle celI s were not stain ed by MoAb FibAS02. D ual-
labeljng with anti-CD31 as endo thelial cell m arker and the MoA b 
FibAS02 perm itted sim ul taneous sta ining of endo the lial cells and 
FibAS02-positive cells. CD3 1 MoAb displayed a d istribu tion tha t 
was clearly d isti nguishabl e fro m tha t of FibAS02, and no coexpres-
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Figure 2. Enhanced expression of antigen FibAS02 during wound 
closure . Granulation- fi broblasts fro t1l two healthy volunteers (A and B) 
iso lated frol11 biopsies at illdicated days after wo undillg were investiga ted by 
Aow cytometry. Cells were used i.n the fo urth passage. T he me:lr1 Auores-
cence intensity (MFC) was used as a paramcter of the binding strength of 
MoAbs to fi broblasts. 
T H E JOUr~NAL OF INVESTIGATI VE DERMATOLOGY 
Figm-c 3. R est r ic ted binding of MoAb F ibAS02 to fi broblasts in 
di fferent human t issucs . T he rea ~t ion patterns of MoAbs were examined 
with im munohistochemica l methods. A and B. skin ; C, double-stain ing 
experiments with anLi-CI 3 1 as endothe lia l cell Illarker (red) and MoAb 
FibAS02 (bro ll' /I ) ill skin sections; D alld E. MoAb FibAS02 (0) and and 
anti-vim entin (E) binding in cartilage; F and C, lI1uscul ar tissue (F, sl11 00th 
muscle cell s; C. skeletal rnuscle fibers beside the fi brobl asts ill tendon) ; H, 
lymph node; I , placcnta; K, kidney: L, ga ll bladder wa ll ; M , thyroid gland . 
Bnr, 25 p.m. 
sio n of these m arkers was o bserved (Fig 3 C), indi cating that MoAb 
Fi bAS02 does not react w ith endothelial ce lI s i ll silll . In the same 
manner , we co uld not find co expression o f FibAS02 w ith CD68, a 
m arker fo r m acroph ages , w ith CD l a for Lan gerh ans celIs o r wi th 
£x- smooth muscle cell actin fo r sm ooth m uscle cells (data not 
shown). 
The Immunoh istologic Studies o f Several O rgans P rove the 
Restric tion of the M oAb F ibAS02 t o F ibroblas ts To dem-
on strate the expressio n of the antigens FibASOl and FibAS02 in 
o ther ti ssues, we pel-form ed immunohi stologic studies on cryosta t 
sections of cartil age, tendon , lymph no des, kidney, ga ll b ladder, 
th yroid gland, muscle, and placenta. MoAb Fi bAS02 recognized 
fibrobl asts independent of tissue orig in in all ti ssues tested . 
Neithe r an tibo dy reacted w ith cho ndrocy tes (F ig 3D), which 
were stain ed wi th the pan- m esench ym al cell m arker anti-vimen tin 
(F ig 3E). In histo logic sectio ns of stomach , we veri fie d that MoAb 
FibAS02 did not stain sm ooth mu scle cells. In contrast, fib roblasts 
in the connecti ve ti ssue between the smooth muscle cells were 
stain ed intensely with the MoA b (F ig 3F) . T he an tibo dy also d id 
not iden tify skeletal muscle fi bers (Fig 3G). In lymph nodes, the 
MoAb l=ibAS02 sta in ed fi broblasts, but no reactivity w as observed 
in lymphocytes in either the fo llicul ar cen te rs o r the mantle zone 
(F ig 3R) . T he pl acen ta was exa mined to study the reactivity of the 
M oAb Fib AS02 to m esenchym al ti ssue and endotheli al cell s in 
newly fo rmed connective tissue . Signals were limited to th e 
mesench ym al ce lls. T h e epith elium (cytotropho bl ast, syncytio tro-
pho blast, amni o n-epi thelium) , sm ooth muscle cells, and endothe -
lial cells fail ed to stain . T he absen t staining o f the end o thelial cells 
is in agreem ent w ith the fl ow cytom etry and immunohistologic 
results fi'o m other ti ssues (F i g 31) . R.eactivity of MoAb FibAS02 in 
sections of kidney (Fig 3K), ga ll bl adder (F ig 3L), and thyroid 
gland (Fig 3M) was o bserved o nl y o n fi brobl asts in the connective 
tissue. In the ki dney, stained cell s, w hich are pro babl y I11csangiulll. 
cells, were also fo und in the glom eruli . In proxim al tubule of the 
kidney, th e luminal m emb rane of the epi the lium was srained in 
experim en ts using the alka lin e phosphatase anti-alkaline phos-
phatase technique. T he MoAb Fib ASOl showed the sa me staining 
patte rn in a ll ti ssues tested , and the resul ts of both an tibodics aI:e 
summa rized ill T a ble I. 
Im munoele ctron Microscopy In F ig 4, labe ling w itll M oAb 
FibA02 was fo und o n the m em b rane surface of human derm al 
peri vascul ar fibro blasts by pre- embeddin g immunoelectron micros-
copy. T he 5 -11111 gold par ticles were di stributed not only on th e 
veil-like proj ections of the fibro blas ts b ut also ove r the w hole cell 
m embrane. Loca ljzed clu ste ring of gold particles at a specific site 
(e.g., cell-cell o r cell-m atrix contacts) was no t o bserved . T h e 
an tibo d y did no t stain pericytes, endotheli al cells, o r the extracel-
lular m atri x. In the case of pericytes, false-negati ve resul ts cannot 
be ruled o u t, beca use of limited gold particle pene tratio n thro ugh 
the basal m embrane that surrounds these ce lls. Beca use a pre-
embed ding approach w as used , we could not determine the 
possible intracellul ar di stributi o n o f the epito pe. N o rmal mo use 
serum , used as a negative contro l, showed no specific labelin g . 
T he MoAhs F ibAS01 a nd FibAS02 Do Not Bind to Proteins 
of Extracellular Matrix In en zym e-linked iml11unosorbent a -
says, we dem onstrated that MoAbs FibASO l and FibAS02 did not 
bind to the m aj o r m atrix compo nents of the conn ective ti ssue, 
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Table I. Reactivity of MoAbs FibASOl and FibAS02 in 
Human Tissues" 
Connective tissue 
Fibroblasts 
Fat cells 
Endothelia l ce ll s 
Cel ls of glandu las 
C hondrocytes 
Muscle 
Smooth muscle 
Skeleton muscle fibers 
Liver/gall bladder 
Epithelium 
Endothelium 
Parenchyma 
Kidney 
Glomeruli 
Tubulus epithelium 
Lymphatic tissue 
Lymphocytes 
Placenta 
Mesenchyme 
Epithelium 
Endothelium 
Umbilical cord 
Endothelium 
+ 
+ 
I I In vestigated using immun ohistochemical techniques described ill A/lf/ferials nlld 
Met/lods . 
,. Occasioll:li cell s were smincd. 
collagen I, III, IV, fibronectin, or laminin, whereas control anti-
bodies di.rected against collage n I-lII, rv, fibronectin, or laminin 
clearly detected the matrix components (Table II) . 
Determination of the Species Specificity ofMoAbs FibASOl 
and FibAS02 The reactivity of the MoAbs with human fibro-
blasts was compared with fibroblasts from mouse, rat, and pig. 
Mouse and rat cells failed to stain with both MoAbs, which was 
TH E JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Table II. MoAbsFib ASOl and FibAS02 do not react with 
extracellular ·matrix proteins" 
Control without 
MoAb 
MoAb FibASOl 
MoAb FibAS02 
Anti-collagen I-III 
Anti-Iaminin 
Anti-flbronectin 
Collagen I, III, IV/ Laminin 
+ 
+ 
Fibronectin 
+ 
" The binding of the MoAbs FibASOl OIld FibAS02 to fibronectin and to a mixrure 
of collage n I and III and larninin was examined in enzyme-linked immull oSorben[ 
assay, whkh was proven with control alltibodies ("0 coll agen. 1:lminin, and fibroncctin. 
respectively. 
supported and extcnded for tissue reactiv ity conccrning mouse and 
pig (data not shown). 
The MoAb FibAS02 Detects Molecules With a MW of - 60-65 
kDa and 30-35 kDa In western blot analysis, we demonstrated 
that MoAb FibAS02 reacts with molecules of MW of - 60-65 kDa 
and 30-35 kDa under nonreducing conditions, whereas under 
redu cing conditions, only the 60-65 kDa molecule is detectable 
(Fig 5). Immunoblots using MoAb FibASOl showed the same 
results as described for FibAS02 (data not shown). 
DISCUSSION 
The data presented here demonstnlte that MoAbs FibASOl and 
FibAS02 are fibroblast-specific MoAbs. In flow cytometry and 
immunohistologic experim ents, we demonstrated that the MoAhs 
react with aU fibroblasts, both i.n cell culture and ill sit" in various 
tissues. The expression of the corresponding antigens was indepen-
dent of age, stage of proliferation, 0 .. tissue origin of fibroblasts, 
indicating that they are expressed constitutively in these cells. 
Furthermore, we showed restricted binding of the MoAbs to 
fibroblasts by flow cytometry and immunohistologic i.nvestigations 
Figure 4. Indirect immunoelectron microscopy with 5-nm gold particles and MoAb FibA02. A microvascular " .. tecial cap illary in the hum,u1 
dermis is shown. El}" erythrocyte; Em/, endothelial cell; Pcr, pericyte; BM. basal m embrane; Fb, fibroblast. Scale bo,.l. 7 p.m. 0 and b show higher m agnification 
of the parts of 0 in the black I",xes. Note the labelillg on the outside of the cellmembrnne of veil-like projections of two periv"scuhlr fibroblasts (oI1"ol/ls). N o 
labe ling was seen 01] the ce ll membrane of the pericyte in the IIpper It;/i co ,."er of n. Scale IJar, 0.4 p.m. 
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figure 5 _ The MoAb FibAS02 recognizes 60-65 kDa and 30-35 kDa 
molecules in western blot. Fibroblast extracts were obtained as de -
scribed in Materials alld Methods and subjected to w"stern blot ana lysis . 
Detection of MoAb binding was performed w ith enhanced chemi lumines-
cence. A, reducing; BIC, no nreducing conditio ns. 
of different cell types and ti ssues. In dual-labeling experiments, We 
confirmed these results for specific ce ll types such as endothelia l 
cells, rnacrophages, smooth muscle cells, and Langerhans cells. Th,e 
reactivity of the MoAbs with components of the extracellula r 
J11atl-ix vvas excluded using enzyme-linked il11111unosorbent assays 
an d in"lnlUnoelectron microscopy, The chara cterization of the 
MoAb s c larified that we have successfuUy establi shed fibrob l;tst-
specific MoAbs, 
T h e investigation of the cellular localization of the an tige l1s 
FibAS01 and FibAS02 usin g immunofluorescence and imml1l'lo-
electron microscopy indicates that th e epitope is located on the 
outside of the fibroblast cell m embrane. Ultrastru ctu ral analysis 
revea l ed an even distribution over the whole cell surface. At 
present, it is unknown whether the antigens or precursors Cll::e 
located in the cytoplasm as well. 
Because in western blot analysis a molecule of 60-65 kDa Was 
detecta ble under redu cing and nonreducing conditions, we COI') -
c1ude that the antigens consist of one polypeptide chain . The 
additional lower band at 30-35 kDa may represent fi'agments of the 
upper one, because the band is broad and sometimes dilfuse. At ~his 
time, there is no explanation for the dilferent behavior of the bands 
under reducing and non reducing conditions. Isolati on and strUc-
rural characterizations of the antigens are under way to clarify the 
physiolog ical rol e of the antigens . 
Interestingly, using flow cytometry, we observed an increas~d 
expression of the antigens FibASOl and FibAS02 o n fibrobl as ts 
during vvound hea ling compared with quiescent fibroblasts. T hese 
differences, as well as other determin ed parameters, were stable 
with passages and are not dependent on the ill Il i llO conditio ns. lt 
seen'1.S noteworthy that fibroblasts in the environment of inflamtl1 ;a-
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tOI'y events or tumor growth showed intense stammg with the 
MoAbs FibASO l o r FibAS02 in immunohistologic stndies (data not 
shown). T hese data suggest that the correspondin g antigens might 
participate in the activation of fibrobla sts , but upregulation of these 
antigens o n cultured fibroblasts could not be detected after incu-
bation of the cells w ith inflammatory cytokines (tumor necrosis 
f.,cto r-a, tr'lI1sfonnin g growth factor- /3, and platelet-derived 
growth r.,cto r, All form). 
In view of the identical data obtained w ith both antibodies in 
flow cytometry, immunohistochemistry, and western blot analysis, 
we believe that both MoAbs recognize the same antigen. The 
MoAbs FibASOl and FibAS02 presented here are novel fibroblast-
specific an tibodies that recognize a m embrane-bound antigen . The 
antibodies sho uld provide a powed'-ll and universal tool for the 
identification and elfective isolation o r e li mination of tib roblasts 
frol11 crude tissue extracts. 
Tll is " fO,.k ,,'as slIpp,lI1ed by n .~rn"t ./i'lll" tile Delltscllc F{)"srlllltlgsc~c",cillsrllaJ; ( He 
2 '1-161 /-1 ). 
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